Let’s Talk About the Opportunity for RxKeeper
You already know the problem—medication non-adherence costs the healthcare system $528 billion a year and leads to 125,000 preventable deaths annually.
It’s clear… The question IS NOT if the market needs a solution.
The question is who will dominate this sector?
A Market in Transition
The medication adherence market is exploding:
​
-
$3.2 billion in 2022, projected to reach $11.03 billion by 2031, growing at 14.9% CAGR (insightaceanalytic.com).
-
Medicare is now reimbursing adherence tracking—meaning providers are financially incentivized to adopt it.
-
FDA & CMS regulations are tightening—payers and clinical trials must improve adherence reporting.
This isn’t speculation. The shift is happening now. The companies that move first will dominate the sector.
Why RxKeeper is Set to Lead the Market
FDA-Registered, Class 1 Medical Device – Already approved, already compliant, no waiting.
Product is In Stock & Ready to Sell – This is not a prototype or an R&D project—RxKeeper® is selling now.
​
Medicare-Backed Revenue Model – Providers can immediately bill up to $136 per patient/month for RTM services.
Limited Competition – RxKeeper is the world’s first & only battery-powered cellular adherence device.
Strategic Alliance with Global IoT Leader – Partnered with a Japanese firm with 5M+ IoT devices deployed.
Validated for Refrigerated Medications – Expanding into high-value specialty drug markets.
While potential competitors struggle to figure out compliance, RxKeeper® is already here … in stock.
Why This Works as an Investment
​
RxKeeper isn’t just a great healthcare product. It’s a revenue engine.
​
RTM Reimbursement Breakdown:
-
CPT 98975 – RTM Initial Setup & Education ($19 per patient).
-
CPT 98977 – RTM Device Supply & Monitoring (30 Days) ($47 per patient).
-
CPT 98980 – Monthly RTM Treatment Management (First 20 Minutes) ($50 per patient).
-
CPT 98981 – Additional RTM Treatment Management (Each Additional 20 Minutes) ($39 per patient).
​
Recap:
-
1,000 patients = $136,000 per month.
-
10,000 patients = $1.36 million per month.
-
100,000 patients = $13.6 million per month.
The initial investors who recognize this shift will secure a dominant stake in a fast-growing market.
Time is NOT our Friend
There are two types of investors:
​
-
Those who see the opportunity and act before the market catches up.
-
Those who watch others make dominant globally
The companies set to take over the medication adherence market in the next 12-18 months will define the next decade of digital health.
​
The question is: Who will be the key players?
​
→ Request a Private Investment Call
Six months from now, someone will be counting their revenue. Will it be you?